Date: 2015-11-05
Type of information: Licensing agreement
Compound: phage display library
Company: Agenus (USA - MA) Iontas (UK)
Therapeutic area: Technology - Services
Type agreement: licensing
Action mechanism:
Disease:
Details: * On November 5, 2015, Agenus obtained an exclusive license to a phage display library from IONTAS. The transaction with IONTAS (Cambridge, UK) further strengthens our suite of best-in-class approaches to developing and optimizing antibodies as potential new medicines.
Financial terms:
Latest news:
